News
Gujarat FDCA receives Rs. 32 crore from state govt to expand Surat drug testing lab: Shardul Nautiyal, Mumbai Thursday, ...
AN2 Therapeutics completes dosing first single ascending dose cohort in phase 1 first-in-human clinical trial of oral AN2-502998 for Chagas disease: Menlo Park, California Thursda ...
Xspray Pharma enters license agreement with Handa Therapeutics to commercialize dasatinib product in US & selected Asian markets: Sweden Thursday, August 14, 2025, 11:00 Hrs [IST] ...
Brazilian Health Regulatory Agency approves Enable Injections’ enFuse system for administration of medication subcutaneously: Cincinnati Thursday, August 14, 2025, 10:00 Hrs [IS ...
US FDA grants fast track designation to AAVantgarde Bio’s AAVB-039 to treat Stargardt disease: Milan Thursday, August 14, 2025, 09:00 Hrs [IST] AAVantgarde Bio (AAVantgarde), a ...
IPC 74th edition to chalk out next-gen pharma strategy in industry and education: Prof Milind Umekar
Nandita Vijayasimha, Bengaluru Thursday, August 14, 2025, 08:00 Hrs [IST] ...
Deadline extended for filing responses in anti-dumping probe on PNT imports from EU: Shardul Nautiyal, Mumbai Thursday, August 14, 2025, 08:00 Hrs [IST] The Directorate General of ...
Ayush ministry & FSSAI jointly release official list of approved "Ayurveda Ahar" products: Peethaambaran Kunnathoor, Chennai Thursday, August 14, 2025, 08:00 Hrs [IST] In a signif ...
CDSCO issues draft standards for IVD medical devices evaluation protocol: Gireesh Babu, New Delhi Thursday, August 14, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Org ...
Abcentra begins patient dosing in phase 2b FORTIFY trial evaluating orticumab in patients with cardiovascular disease: Los Angeles Wednesday, August 13, 2025, 18:00 Hrs [IST] Abce ...
Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...
Our Bureau, Mumbai Wednesday, August 13, 2025, 17:20 Hrs [IST] Sino-international trade is accelerating as CPHI & PMEC China he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results